Meiwu Technology completes $35M Hemeitong acquisition

Meiwu Technology Company Limited (WNW), through its wholly and indirectly owned subsidiary Xiamen Chunshang Health Technology Co., Ltd., completed the acquisition of 100% of Xiamen Hemeitong Commercial Co., Ltd.’s equity interests on September 22, 2026.

Rhea-AI Filing Summary

Meiwu Technology Company Limited (WNW), through its wholly and indirectly owned subsidiary Xiamen Chunshang Health Technology Co., Ltd., completed the acquisition of 100% of Xiamen Hemeitong Commercial Co., Ltd.’s equity interests on September 22, 2026. The acquisition was pursuant to an equity transfer agreement dated August 20, 2026, among Xiamen Chunshang, Xiamen Hemeitong and two of Xiamen Hemeitong’s shareholders.

At closing, Meiwu paid the sellers RMB235,200,000 in cash, approximately $35,000,000, as consideration. Xiamen Hemeitong became a wholly owned subsidiary of Xiamen Chunshang.

Key Figures

Equity interests acquired: 100% Cash consideration: RMB235,200,000 Approximate cash consideration: Approximately $35,000,000

3 metrics

Equity interests acquired 100% Xiamen Hemeitong; completed September 22, 2026

Cash consideration RMB235,200,000 Paid to the sellers at closing

Approximate cash consideration Approximately $35,000,000 U.S. dollar equivalent stated for the consideration

Key Terms

equity transfer agreement, equity interests, wholly owned subsidiary

3 terms

equity transfer agreement financial

"pursuant to an equity transfer agreement"

An equity transfer agreement is a legal contract that records the sale or reassignment of ownership in a company’s shares from one party to another. Like handing over the keys when you sell a house, it changes who legally controls those ownership rights and any attached voting power or dividend claims. Investors care because such transfers can shift control, dilute or concentrate stakes, affect company strategy and influence future share value.

equity interests financial

"in exchange for 100% equity interests of Xiamen Hemeitong"

Equity interests are an ownership stake in a company—usually represented by shares or membership units—that give the holder a claim on the business’s profits, assets and sometimes voting power. Think of it as owning one or more slices of a company’s pie: the bigger your slice, the larger your share of dividends, capital gains and influence, and the more you are affected by dilution or company losses. Investors use equity interests to measure value, control and potential returns.

wholly owned subsidiary financial

"Xiamen Hemeitong became a wholly owned subsidiary"

A wholly owned subsidiary is a company whose entire ownership is held by another company (the parent), so the parent controls decisions, operations, and finances. Think of it as a fully controlled branch that runs as its own legal entity but whose results flow straight into the parent’s financial statements; investors watch these structures because they affect consolidated revenue, risk exposure, and how profits, liabilities, and cash flow are allocated across the corporate group.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did WNW pay for Xiamen Hemeitong?

Meiwu paid the sellers RMB235,200,000 in cash, approximately $35,000,000, as consideration at closing on September 22, 2026.

What percentage of Xiamen Hemeitong did WNW acquire?

Meiwu’s subsidiary Xiamen Chunshang acquired 100% of Xiamen Hemeitong’s equity interests. Xiamen Hemeitong became a wholly owned subsidiary of Xiamen Chunshang when the acquisition closed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 04:16 PM Accepted by SEC EDGAR 09/23/2026 - 04:15 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2026

Commission File Number: 001-39803

Meiwu Technology Company Limited

(Translation of registrant’s name into English)

Unit 304-3, No.19, Wanghai Road, Siming District

Xiamen, Fujian, People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Completion of Acquisition or Disposition of Asset

On September 22, 2026, Xiamen Chunshang Health Technology Co., Ltd (“Xiamen Chunshang”), a wholly and indirectly owned subsidiary of Meiwu Technology Company Limited (the “Company”), completed its previously announced acquisition of 100% equity interests of Xiamen Hemeitong Commercial Co., Ltd. (“Xiamen Hemeitong”) pursuant to an equity transfer agreement (the “Agreement”, the transaction contemplated therein, the “Acquisition”) by and among Xiamen Chunshang, Xiamen Hemeitong, and two shareholders of Xiamen Hemeitong (the “Sellers”), dated as of August 20, 2026. Upon closing, the Company paid an aggregate of RMB235,200,000 (approximately $35,000,000) in cash as consideration to the Sellers in exchange for 100% equity interests of Xiamen Hemeitong, and Xiamen Hemeitong became a wholly owned subsidiary of Xiamen Chunshang.

Below is a diagram that illustrates the Company’s corporate structure immediately after the closing of the Acquisition:

 

* unless otherwise indicated, the percentage of the ownership is 100% in the chart above.

2

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Current Report on Form 6-K contains express or implied forward-looking statements that are based on our management’s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events, potential acquisition opportunities, or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements in this Current Report on Form 6-K include, but are not limited to, statements about:

	●	the implementation of our strategic plans for our business;
	●	our ability to consummate an attractive acquisition and realize the benefits of such transaction;
	●	developments relating to our competitors and our industry;
	●	estimates of our expenses, future revenues, capital requirements and our needs for additional financing; and
	●	other risks and uncertainties.

In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “could,” “project,” “intend,” “will,” “will be,” “would,” or the negative of these terms or other comparable terminology and expressions. However, this is not an exclusive way of identifying such statements. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section entitled “Risk Factors” and elsewhere in this Current Report on Form 6-K. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this Current Report on Form 6-K and the documents that we reference in this Current Report on Form 6-K and have filed with the U.S. Securities and Exchange Commission (“SEC”) as exhibits hereto completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements.

The forward-looking statements in this Current Report on Form 6-K represent our views as of the date of this Current Report on Form 6-K. We anticipate that subsequent events and developments will cause our views to change. Except as expressly required under federal securities laws and the rules and regulations of the SEC, we do not undertake any obligation to update any forward-looking statements to reflect events or circumstances arising after the date of this Current Report on Form 6-K, whether as a result of new information or future events or otherwise. You should therefore not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Current Report on Form 6-K. You should not place undue reliance on the forward-looking statements included in this Current Report on Form 6-K. All forward-looking statements attributable to use are expressly qualified by these cautionary statements.

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: September 23, 2026

	Meiwu Technology Company Limited
	By:	/s/ Changbin Xia
	Name:	Changbin Xia
	Title:	Chairman of the Board

4